Servier in the U.S. is a Boston-based, commercial-stage biopharmaceutical company launched by Servier Group in 2018. As a privately held organization, Servier is uniquely positioned to advance cutting-edge science, tackle underserved therapeutic areas and make patients the focus of every strategic decision. We are seeking top tier candidates to join our team as it strives to achieve its vision of developing innovative medications to transform the lives of patients. The Sales Director is a key member of the sales leadership team in addition to overseeing their individual region. This person will be a frontline leader and responsible for continuing to lead, coach, and develop our existing sales teams. The Sales Director will work closely with commercial leadership, marketing, marketing analytics, market access, patient advocacy, and medical affairs to ensure alignment and to meet corporate objectives. This position reports to the National Sales Director - Hematology. The Sales Director and team of Sr. Oncology Consultants will sell IDHIFA® (enasidenib), an approved IDH2m inhibitor, and Tibsovo® (ivosidenib), an approved IDH1m inhibitor, both indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (R/R AML) having tested positive for the respective IDH mutation. The Sales Director and Sr. Oncology Consultants will also sell Tibsovo® (ivosidenib) as an approved front-line treatment for adults with newly diagnosed AML. The Sales Director and Sr. Oncology Consultants will also sell Tibsovo® (ivosidenib) for relapsed or refractory myelodysplastic syndrome (R/R MDS) having tested positive for the IDH1 mutation. The Sales Director and team of Sr. Oncology Consultants will sell Asparlas, an approved component of a multi-agent chemotherapy regimen for the treatment of acute lymphoblastic leukemia (ALL) in pediatric and young adult patients aged 1 month to 21 years, and Oncaspar, an approved component of a multi-agent chemotherapy regiment for first line treatment of acute lymphoblastic leukemia (ALL) in pediatric and young adult patients.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Education Level
Bachelor's degree
Number of Employees
251-500 employees